Dr Reddys Laboratories RDY
NYSE RDY
$13.26 +0.18 (+1.38%)
As of: Oct 20, 2026 · 3:59 PM EDT

Dr Reddys Laboratories (RDY) Shares Outstanding (Diluted) (2009 - 2026)

Updated

Dr Reddys Laboratories (RDY) posted Shares Outstanding (Diluted) of 833.33 million for the quarter ended Jun 30, 2026, down 0.1% from 834.18 million a year earlier and unchanged from the prior quarter.

Analysis

Dr Reddys Laboratories (RDY) Shares Outstanding (Diluted) (2009 - 2026) Analysis & Trends

Since the quarter ended Mar 31, 2009, Dr Reddys Laboratories has reported Shares Outstanding (Diluted) for 68 quarters.

  • Annual Shares Outstanding (Diluted) shows a five-year compound annual growth rate of 0.0% (years ended Mar 2021 to Mar 2026).
  • In prior years, Dr Reddys Laboratories' Shares Outstanding (Diluted) was 834.18 million in the year ended Mar 31, 2025 (+0.1%), 833.54 million in the year ended Mar 31, 2024 (+0.2%), 831.94 million in the year ended Mar 31, 2023 (unchanged) and 831.69 million in the year ended Mar 31, 2022 (unchanged).
  • Quarterly Shares Outstanding (Diluted) has run from a low of 831.58 million in the quarter ended Sep 30, 2021 to a high of 834.18 million in the quarter ended Dec 31, 2025 over five years.
  • On a year-over-year basis, Shares Outstanding (Diluted) increased in six of the last eight quarters, with growth averaging 0.1%.
  • According to Business Quant data, Shares Outstanding (Diluted) for the three prior quarters was 833.33 million (quarter ended Mar 31, 2026), 834.18 million (quarter ended Dec 31, 2025) and 834.18 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 893.70 Mn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 2.44 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 1.77 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 2.47 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 1.56 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 544.00 Mn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 1.24 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 5.70 Bn
10 Dr Reddys Laboratories 11.03 Bn 10.40 Bn 396.53 Mn 833.33 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 833.33 Mn
Mar 31, 2026 833.33 Mn
Dec 31, 2025 834.18 Mn
Sep 30, 2025 834.18 Mn
Jun 30, 2025 834.18 Mn
Mar 31, 2025 834.18 Mn
Dec 31, 2024 833.54 Mn
Sep 30, 2024 833.54 Mn
Jun 30, 2024 833.54 Mn
Mar 31, 2024 833.54 Mn
Dec 31, 2023 831.94 Mn
Sep 30, 2023 831.94 Mn
Jun 30, 2023 831.94 Mn
Mar 31, 2023 831.94 Mn
Dec 31, 2022 831.69 Mn
Sep 30, 2022 831.69 Mn
Jun 30, 2022 831.69 Mn
Mar 31, 2022 831.69 Mn
Dec 31, 2021 831.58 Mn
Sep 30, 2021 831.58 Mn
API Access

Dr Reddys Laboratories Shares Outstanding (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=RDY&period=max&api_key=YOUR_API_KEY